Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
News: Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
All NewsEconomyCurrencies & ForexEconomic EventsCryptocurrenciesCybersecurityPress Releases

Health Care Up On Defensive Bias -- Health Care Roundup

04/20/2021 | 05:53pm EDT

Health-care companies rose as investors rotated into defensive sectors amid worries about the pace of the economic recovery.

Johnson & Johnson shares rose after the health-care conglomerate posted first-quarter profit ahead of some investors' expectations, even as its vaccine sales outlook was complicated by pauses in vaccinations while health authorities in several countries probe safety concerns.

J&J rival Pfizer is likely to generate $24 billion in sales from its Covid-19 vaccine this year, with Moderna, another vaccine maker, likely to generate $14 billion in sales from its own shot, according to analysts at brokerage Bernstein.

 Write to Rob Curran at rob.curran@dowjones.com 

(END) Dow Jones Newswires

04-20-21 1752ET

Stocks mentioned in the article
ChangeLast1st jan.
DJ INDUSTRIAL 1.39% 34055.77 Delayed Quote.11.97%
MODERNA, INC. 0.33% 153.33 Delayed Quote.46.15%
PFIZER, INC. 1.03% 40.105 Delayed Quote.6.90%
Latest news "Economy & Forex"
10:53aColonial Pipeline paid hackers nearly $5 million in ransom - Bloomberg News
10:49aHyundai Motor to invest $7.4 billion in the U.S. by 2025
10:47aUK government, watchdog pledge action to protect cash
10:45aTop U.S. fuel pipeline recovering from devastating ransomware attack
10:40aWORLD BANKá : Sri Lanka, World Bank sign agreement for COVID-19 Vaccine Deployment
10:36aMake Tesla Great Again
10:35aU.S. weekly jobless claims decline; producer prices accelerate
10:27aFord redesigning parts to use more accessible chips, weighing direct deals with chip foundries
10:26aTSX edges higher on healthcare boost; energy stocks fall
10:26aThe EBA observes achievements in a number of key areas of the supervisory review across the EU, but also highlights items requiring continued attention
Latest news "Economy & Forex"